No Data
No Data
J&J, Stryker Among Potential Suitors for Nevro: Wolfe
Johnson & Johnson Announces Groundbreaking Nipocalimab Study Of Pregnant Individuals At High Risk For Early Onset Severe Hemolytic Disease Of The Fetus And Newborn Published In The New England Journal Of Medicine
Express News | J&J - Labeling Update for Linx Reflux Management System Will Provide More Patients Relief From Gastroesophageal Reflux Disease
Express News | Johnson & Johnson Medtech Announces Labeling Amendment of Linx™ Reflux Management System in U.S. to Include Patients With Barrett's Esophagus Experiencing Gastroesophageal Reflux Disease
Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?
Johnson & Johnson's (NYSE:JNJ) Investors Will Be Pleased With Their Favorable 37% Return Over the Last Five Years
No Data
KC67 Chan : Will it continue a losing streak ?
Kraks : Any comments on Shopify?
103365182 : Will be more coming soon.
Cow Moo-ney OP Kraks : Sorry i don’t quite follow the company
Cow Moo-ney OP KC67 Chan : Probably?
View more comments...